S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
NASDAQ:TNYA

Tenaya Therapeutics - TNYA Short Interest Ratio & Short Volume

$2.53
-0.03 (-1.17%)
(As of 03/24/2023 05:19 PM ET)
Add
Compare
Today's Range
$2.42
$2.58
50-Day Range
$2.29
$3.59
52-Week Range
$1.64
$14.43
Volume
345,171 shs
Average Volume
380,938 shs
Market Capitalization
$169.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.33

Tenaya Therapeutics Short Interest Data

Current Short Volume
782,600 shares
Previous Short Volume
872,200 shares
Change Vs. Previous Month
-10.27%
Dollar Volume Sold Short
$2.40 million
Short Interest Ratio / Days to Cover
2.7
Last Record Date
February 28, 2023
Outstanding Shares
66,860,000 shares
Float Size
38,040,000 shares
Short Percent of Float
2.06%
Today's Trading Volume
345,171 shares
Average Trading Volume
380,938 shares
Today's Volume Vs. Average
-9.39%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Tenaya Therapeutics ?

Sign up to receive the latest short interest report for Tenaya Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TNYA Short Interest Over Time

TNYA Days to Cover Over Time

TNYA Percentage of Float Shorted Over Time

Tenaya Therapeutics (NASDAQ:TNYA) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/28/2023782,600 shares $2.40 million -10.3%2.1%2.7 $3.07
2/15/2023872,200 shares $2.67 million +3.9%2.3%2.7 $3.06
1/31/2023839,400 shares $2.87 million -2.4%2.1%2.3 $3.42
1/15/2023859,600 shares $1.97 million +2.4%2.2%2.8 $2.29
12/30/2022839,300 shares $1.69 million -15.2%2.1%3.1 $2.01
12/15/2022990,000 shares $2.35 million -14.7%2.0%3.6 $2.37
11/30/20221,160,000 shares $3.07 million -10.1%2.7%4.4 $2.65
11/15/20221,290,000 shares $3.78 million -0.8%3.1%5.6 $2.93
10/31/20221,300,000 shares $3.48 million -13.3%4.6%8.2 $2.68
10/15/20221,500,000 shares $3.69 million -1.3%5.3%9.3 $2.46
9/30/20221,520,000 shares $4.41 million No Change5.4%8.8 $2.90
9/15/20221,520,000 shares $6.10 million -6.2%5.4%8.4 $4.01
8/31/20221,620,000 shares $7.11 million -10.0%5.7%9.6 $4.39
8/15/20221,800,000 shares $10.31 million -26.8%6.4%10.9 $5.73
7/31/20222,460,000 shares $11.73 million No Change8.7%16.8 $4.77
7/15/20222,460,000 shares $12.79 million -39.0%8.7%19 $5.20
6/30/20224,030,000 shares $22.69 million +7.2%14.3%34.8 $5.63
6/15/20223,760,000 shares $20.45 million +1.6%13.3%34.6 $5.44
5/31/20223,700,000 shares $24.79 million -1.1%13.1%27.8 $6.70
5/15/20223,740,000 shares $26.55 million -0.5%13.3%25.4 $7.10
4/30/20223,760,000 shares $34.67 million +1.1%13.3%24.4 $9.22
4/15/20223,720,000 shares $42.56 million +1.6%13.2%22.7 $11.44
3/31/20223,660,000 shares $43.11 million +13.3%13.0%19.9 $11.78
3/15/20223,230,000 shares $37.08 million +10.6%11.4%17 $11.48
2/28/20222,920,000 shares $34.05 million +4.3%10.3%18.2 $11.66
2/15/20222,800,000 shares $42.53 million +4.9%9.9%18.4 $15.19
1/31/20222,670,000 shares $31.83 million +6.8%10.2%18.4 $11.92
1/15/20222,500,000 shares $25 million +25.6%9.5%19.2 $10.00
12/31/20211,990,000 shares $37.71 million No Change7.6%16.8 $18.95













TNYA Short Interest - Frequently Asked Questions

What is Tenaya Therapeutics' current short interest?

Short interest is the volume of Tenaya Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 28th, traders have sold 782,600 shares of TNYA short. 2.06% of Tenaya Therapeutics' shares are currently sold short. Learn More on Tenaya Therapeutics' current short interest.

What is a good short interest ratio for Tenaya Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TNYA shares currently have a short interest ratio of 3.0. Learn More on Tenaya Therapeutics's short interest ratio.

Which institutional investors are shorting Tenaya Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Tenaya Therapeutics: Group One Trading L.P., Simplex Trading LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Tenaya Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.06% of Tenaya Therapeutics' floating shares are currently sold short.

Is Tenaya Therapeutics' short interest increasing or decreasing?

Tenaya Therapeutics saw a decrease in short interest in February. As of February 28th, there was short interest totaling 782,600 shares, a decrease of 10.3% from the previous total of 872,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Tenaya Therapeutics' float size?

Tenaya Therapeutics currently has issued a total of 66,860,000 shares. Some of Tenaya Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tenaya Therapeutics currently has a public float of 38,040,000 shares.

How does Tenaya Therapeutics' short interest compare to its competitors?

2.06% of Tenaya Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Tenaya Therapeutics: C4 Therapeutics, Inc. (7.97%), Adaptimmune Therapeutics plc (1.98%), Acumen Pharmaceuticals, Inc. (2.29%), Fusion Pharmaceuticals Inc. (0.74%), Genfit S.A. (0.21%), Ocugen, Inc. (21.85%), Molecular Partners AG (0.04%), Jasper Therapeutics, Inc. (4.14%), Century Therapeutics, Inc. (8.86%), and Ikena Oncology, Inc. (1.16%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Suncor Energy Inc. ($3.27 billion), Occidental Petroleum Co. ($2.77 billion), Coinbase Global, Inc. ($2.25 billion), T. Rowe Price Group, Inc. ($2.23 billion), Paramount Global ($1.92 billion), Etsy, Inc. ($1.75 billion), Voya Financial, Inc. ($1.74 billion), CarMax, Inc. ($1.62 billion), Old Dominion Freight Line, Inc. ($1.62 billion), and Royal Caribbean Cruises Ltd. ($1.39 billion). View all of the most shorted stocks.

What does it mean to sell short Tenaya Therapeutics stock?

Short selling TNYA is an investing strategy that aims to generate trading profit from Tenaya Therapeutics as its price is falling. TNYA shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Tenaya Therapeutics?

A short squeeze for Tenaya Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TNYA, which in turn drives the price of the stock up even further.

How often is Tenaya Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TNYA, twice per month. The most recent reporting period available is February, 28 2023.



This page (NASDAQ:TNYA) was last updated on 3/24/2023 by MarketBeat.com Staff